Skip to main content
. 2021 Jan 8;3(1):100080. doi: 10.1016/j.opresp.2020.100080

Fig. 1.

Fig. 1

Changes in FVC % predicted and DLCO % predicted at one year prior to nintedanib treatment start, at the moment of inclusion and at one year after nintedanib initiation.